RADIOIMMUNOTHERAPY CASES REGISTRY: RECURRENT OR REFRACTORY NON-HODGKIN LYMPHOMA TREATED WITH 90Y-IBRITUMOMAB TIUXETAN

被引：0
|
作者：
Gomez-Codina, J. [1 ]
Giraldo, P. [2 ]
机构：
[1] Univ Hosp La Fe, Valencia, Spain
[2] Hosp U Miguel Servet, Dept Haematol, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [21] Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma
    Fukuno, Kenji
    Tsurumi, Hisashi
    Yamada, Toshiki
    Iida, Takayoshi
    Takahashi, Takeshi
    Moriwaki, Hisataka
    LEUKEMIA & LYMPHOMA, 2013, 54 (12) : 2731 - 2733
  • [22] The role of radioimmunotherapy with yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
    Cheson, BD
    BIODRUGS, 2005, 19 (05) : 309 - 322
  • [23] B-Cell non-Hodgkin lymphoma:: PET/CT evaluation after 90Y-ibritumomab tiuxetan radioimmunotherapy-initial experience
    Ulaner, Gary A.
    Colletti, Patrick M.
    Conti, Peter S.
    RADIOLOGY, 2008, 246 (03) : 895 - 902
  • [24] Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Gordon, LI
    Witzig, TE
    Wiseman, GA
    Flinn, IW
    Spies, SS
    Silverman, DH
    Emmanuolides, C
    Cripe, L
    Saleh, M
    Czuczman, MS
    Olejnik, T
    White, CA
    Grillo-López, AJ
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 87 - 92
  • [25] The Role of Radioimmunotherapy with Yttrium- 90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma
    Bruce D. Cheson
    BioDrugs, 2005, 19 : 309 - 322
  • [26] Diagnostic imaging prior to 90Y-ibritumomab tiuxetan (Zevalin®) treatment in follicular non-Hodgkin's lymphoma
    Otte, Andreas
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2008, 11 (01): : 12 - 15
  • [27] Efficacy of 90Y-ibritumomab tiuxetan (Zevalin) in refractory or relapsed MALT gastric non Hodgkin's lymphoma.
    Vanazzi, Anna
    Ferrucci, Pier F.
    Grana, Chiara
    Pruneri, Giancarlo
    Crosta, Cristiano
    Pinto, Antonello
    Chinol, Marco
    Paganelli, Giovanni
    Martinelli, Giovanni
    BLOOD, 2006, 108 (11) : 784A - 784A
  • [28] 90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
    Ria, Roberto
    Musto, Pellegrino
    Reale, Antonia
    Guariglia, Roberto
    Iodice, Giuseppe
    Dammacco, Franco
    Vacca, Angelo
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) : 891 - 895
  • [29] Spanish registry of radioimmunotherapy:: Analysis of outcomes of patients with recurrent or refractory follicular lymphoma (FL) treated with 90Y ibritumomab tiuxetan (90Y-RIT)
    Giraldo, M.
    Gomez-Codina, J.
    Hernando, T.
    Tisaire, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 277 - 277
  • [30] Therapeutic efficacy and toxicity of 90Y-Ibritumomab tiuxetan in patients with B-Cell non-Hodgkin's lymphoma
    Boni, G.
    Lorenzoni, A.
    Galimberti, S.
    Cecconi, N.
    Genovesi, D.
    Grosso, M.
    Ciuti, S.
    Petrini, M.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S169 - S169
12345